Abstract:There is always a concern about the quality of cell-based products in terms of the contamination of the cells and their lack of efficiency. Therefore, it is very important to ensure these cells' identity, purity, efficacy, and suitability for the production of biological products and diagnostic uses. So, cells must be identified, evaluated, documented, and stored to be used consistently and efficiently. With these conditions, vaccine manufacturers have a suitable reserve of efficient and valuable cells for the production and quality control of biological products. In this review article, a strategic plan for cell-substrate well-characterization and identification according to scientific principles, the author's work experience, and regulatory guidance for the optimal use of that cell in research and diagnostic studies especially for the biological product production process have been drawn. For this purpose, all aspects of cell identification, cell evaluation, and cell characterization are discussed. Because of the importance of cell identity in the competence of a cell substrate, in the cell identification section, all aspects of cell identification, including general cell information, and specific cell characteristics, especially in terms of cell passage history, cell storage conditions, and cell coding and labeling were studied. In the part of cell evaluation and determination of cell characteristics, all tests necessary to determine cell characteristics from various aspects including determination of cell identity, cell growth conditions, cell quality, and efficiency, and the possibility of cell contamination with adventitious agents, including cellular, viral, bacterial, mycoplasma, and mycobacterial agents were introduced. Due to the importance of endogenous virus contamination, this topic is specially discussed. Also, the stability of the cell both from the aspect of genetic stability and from the aspect of stability of cell efficiency, were discussed. In the end, while reviewing the necessary documents to be under the control of the cell for use in the laboratory, based on the studies conducted, the certificate of the cell has been compiled. Therefore, on this basis, the studied cell can be used for research and diagnostic studies of virology, and especially for the production and quality control of biological products.

An industry perspective approach and control strategy for implementation of ready-to-use cells in bioassays: survey outcome and recommendations

A Review for Cell-Based Screening Methods in Drug Discovery

Cell identification, characterization, and documentation for use in the production of biological products

A review for cell-based screening methods in drug discovery.

Recommendations for Method Development and Validation of qPCR and dPCR Assays in Support of Cell and Gene Therapy Drug Development

An Industry Perspective on Compatibility Assessment of Closed System Drug-Transfer Devices for Biologics

Cell Line Culture in Pharmaceutical Development and Application: A Review

The Current State of Biotransformation Science – Industry Survey of In Vitro and In Vivo Practices, Clinical Translation, and Future Trends

Cell cultures in drug discovery and development: The need of reliable in vitro-in vivo extrapolation for pharmacodynamics and pharmacokinetics assessment

Integration of rapid bioburden testing into production quality management systems and process control

Risk-Based Qualification of Cellular Starting Material Collection Sites: Tools to Determine Scope of Manufacturer Audits and Reduce Duplicative Efforts

Benchmarking Organic Micropollutants in Wastewater, Recycled Water and Drinking Water with in Vitro Bioassays

Best Practices in qPCR and dPCR Validation in Regulated Bioanalytical Laboratories

Increasing the Reuse of Protein Non-Naïve Nonhuman Primates in Pharmaceutical Drug Discovery and Development: An Overview and Industry Position on the Challenges and Benefits

Designing of an extract production protocol for industrial application of cell‐free protein synthesis technology: Building from a current best practice to a quality by design approach

High-throughput screening paradigms in ecotoxicity testing: Emerging prospects and ongoing challenges

Single cell analysis of Chinese hamster ovary cells during a bioprocess using a novel dynamic imaging system

Characterization of Critical Reagents in Ligand-Binding Assays: Enabling Robust Bioanalytical Methods and Lifecycle Management

Cell and Gene Therapies: Challenges in Designing Extractables and Leachables Studies and Conducting Safety Assessments

From Discovery to Delivery: A Rapid and Targeted Proteomics Workflow for Monitoring Chinese Hamster Ovary Biomanufacturing

Challenges and gaps in immunosafety evaluation of therapeutics: An IQ DruSafe survey